Edit |   |
---|---|
Antigenic Specificity | CD140a, Human (Tovetumab biosimilar) |
Clone | Tovetumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG2 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IP, IF, FuncS, FCM, Neut, ELISA, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD140a Recombinant Antibody (Tovetumab). Tovetumab is an anti-PDGFRa monoclonal antibody designed for the treatment of cancer. It was developed by MedImmune, and trialed for use in glioblastoma and non-small cell lung cancer. Development was discontinued in 2013. This drug was developed by MedImmune, LLC. |
Immunogen | n/a |
Other Names | Anti-CD140a Recombinant Antibody, Research Grade Tovetumab, Anti-Human CD140a Recombinant Antibody(Tovetumab), MEDI-575, Antibody Drug Analogues, Monoclonal Antibody, YR1314, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1243266-04-7 |
Catalog # | YR1314 |
Price | please inquire |
Order / More Info | CD140a, Human (Tovetumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |